{"DataElement":{"publicId":"7038786","version":"1","preferredName":"Total Gleason Score for Prostate Cancer Finding Score","preferredDefinition":"The description of prostate tissue based on the combination of cancerous glands and cell morphology represented as a numeric value.","longName":"MIGLSNSC","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7038688","version":"1","preferredName":"Microscopic Findings Domain Total Gleason Score for Prostate Cancer Finding","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings._The value of the sum of the primary and secondary Gleason scores (range 2-10). If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiated pattern._Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"6407670v1.0:7038686v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6407670","version":"1","preferredName":"Microscopic Findings Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","longName":"C95095","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Microscopic Findings Domain","conceptCode":"C95095","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to microscopic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F3D377-A300-2627-E053-F662850A04B0","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7038686","version":"1","preferredName":"Total Gleason Score For Prostate Cancer Finding","preferredDefinition":"The value of the sum of the primary and secondary Gleason scores (range 2-10). If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiated pattern.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.","longName":"C48602:C3367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total Gleason Score for Prostate Cancer","conceptCode":"C48602","definition":"The value of the sum of the primary and secondary Gleason scores (range 2-10). If three patterns are identified, it is the sum of the primary pattern score and the score of the least well-differentiated pattern.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"964DCE6D-ED8A-0C14-E053-F662850A025A","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"ONEDATA","dateModified":"2019-11-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"964DCE6D-ED9B-0C14-E053-F662850A025A","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"KUMMEROA","dateModified":"2020-06-17","changeDescription":"Released. AK 2020-6-10; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015237","version":"4","preferredName":"Gleason Score","preferredDefinition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"2015237v4.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":"0","PermissibleValues":[{"value":"10","valueDescription":"Gleason Score 10 ","ValueMeaning":{"publicId":"5918377","version":"1","preferredName":"Gleason Score 10 ","longName":"5918377","preferredDefinition":"A Gleason score that indicates a highly aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 10","conceptCode":"C28094","definition":"A Gleason score that indicates a highly aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5641149B-B351-5B37-E053-F662850A95C2","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":"Updated to correct concept. mc 2/13/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5641149B-B36B-5B37-E053-F662850A95C2","beginDate":"2002-02-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"3","valueDescription":"Gleason Score 3 ","ValueMeaning":{"publicId":"5918384","version":"1","preferredName":"Gleason Score 3 ","longName":"5918384","preferredDefinition":"A Gleason score that is exceptionally assigned and indicates a low-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 3","conceptCode":"C28096","definition":"A Gleason score that is exceptionally assigned and indicates a low-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4DBB-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4DD4-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"9","valueDescription":"Gleason Score 9 ","ValueMeaning":{"publicId":"5918382","version":"1","preferredName":"Gleason Score 9 ","longName":"5918382","preferredDefinition":"A Gleason score that indicates a high-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 9","conceptCode":"C28093","definition":"A Gleason score that indicates a high-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4D6E-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":"Updated to correct concept. mc 2/13/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4D88-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"4","valueDescription":"Gleason Score 4","ValueMeaning":{"publicId":"5918385","version":"1","preferredName":"Gleason Score 4","longName":"5918385","preferredDefinition":"A Gleason score that is relatively uncommon and indicates a low-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 4","conceptCode":"C28097","definition":"A Gleason score that is relatively uncommon and indicates a low-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4DE1-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4DFA-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"5","valueDescription":"Gleason Score 5 ","ValueMeaning":{"publicId":"5918386","version":"1","preferredName":"Gleason Score 5 ","longName":"5918386","preferredDefinition":"An exceptionally uncommon Gleason score that indicates a less aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 5","conceptCode":"C28098","definition":"An exceptionally uncommon Gleason score that indicates a less aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4E07-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":"Updated to correct concept. mc 2/13/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4E21-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"6","valueDescription":"Gleason Score 6 ","ValueMeaning":{"publicId":"5918387","version":"1","preferredName":"Gleason Score 6 ","longName":"5918387","preferredDefinition":"A Gleason score that indicates a low-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 6","conceptCode":"C28090","definition":"A Gleason score that indicates a low-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4E2E-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":"Updated to correct concept. mc 2/13/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4E48-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"7","valueDescription":"Gleason Score 7 ","ValueMeaning":{"publicId":"5918388","version":"1","preferredName":"Gleason Score 7 ","longName":"5918388","preferredDefinition":"A Gleason score that indicates an intermediate-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 7","conceptCode":"C28091","definition":"A Gleason score that indicates an intermediate-grade prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4E55-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":"Updated to correct concept. mc 2/13/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4E6F-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"8","valueDescription":"Gleason Score 8 ","ValueMeaning":{"publicId":"5918389","version":"1","preferredName":"Gleason Score 8 ","longName":"5918389","preferredDefinition":"A Gleason score that indicates a histologically aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 8","conceptCode":"C28092","definition":"A Gleason score that indicates a histologically aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435516-4E7C-1BCA-E053-F662850AE97A","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"TAYLORT","dateModified":"2017-08-08","changeDescription":"Updated to correct concept. mc 2/13/15","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56435516-4E96-1BCA-E053-F662850AE97A","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"},{"value":"2","valueDescription":"Gleason Score 2","ValueMeaning":{"publicId":"5918390","version":"1","preferredName":"Gleason Score 2","longName":"5918390","preferredDefinition":"A low Gleason score that is exceptionally uncommon and indicates a low-grade, non-aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score 2","conceptCode":"C28095","definition":"A low Gleason score that is exceptionally uncommon and indicates a low-grade, non-aggressive prostatic adenocarcinoma. The score or sum is estimated by adding the most prevalent and the second most prevalent histopathologic pattern of the malignant infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"564361CC-31D1-28D1-E053-F662850A64B0","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"564361CC-31EA-28D1-E053-F662850A64B0","beginDate":"2002-02-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5918402","version":"1","preferredName":"Gleason Score for Prostate Cancer Score","preferredDefinition":"A system of grading prostate cancer tissue based on how it looks under a microscope. Gleason scores range from 2 to 10 and indicate how likely it is that a tumor will spread. A low Gleason score means the cancer tissue is similar to normal prostate tissue and the tumor is less likely to spread; a high Gleason score means the cancer tissue is very different from normal and the tumor is more likely to spread.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C28084:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gleason Score for Prostate Cancer","conceptCode":"C28084","definition":"The score derived from universally embraced prostate cancer grading system developed by Dr. Donald F. Gleason in 1977. The system provides a reproducible description of the glandular architecture of prostate tissue to which a pathologist assigns a score depending primarily on the microscopic patterns of cancerous glands and cell morphology. The system correlates well with behavior at the extremes: Gleason 1+1 tumors are the most well differentiated, slowly growing and rarely spread; Gleason 4+5 tumors are the most poorly differentiated, often widely metastatic at the time of diagnosis. In the commoner intermediate grade tumors, however, behavior is extremely variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56435B98-052D-2101-E053-F662850A10FF","latestVersionIndicator":"Yes","beginDate":"2017-08-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-08-08","modifiedBy":"ONEDATA","dateModified":"2017-08-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"56416639-FBC6-1D78-E053-F662850AD6D9","latestVersionIndicator":"Yes","beginDate":"2004-05-17","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2017-08-08","modifiedBy":"COOPERM","dateModified":"2017-12-04","changeDescription":"8/23/17 tt released DN VD. 8/8/17 tt VD versioned for change to rep term, qualifier, def, long name; added CSI and reg status, transferred context per Round 5 finalization task.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318336","version":"1","longName":"Gross Pathology - CDISC Aligned","context":"NCI Standards"},{"publicId":"7318344","version":"1","longName":"Pathology - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[{"name":"MI_MIORRES_GLSNSCORE","type":"OID, CCTG","context":"CCTG"}],"ReferenceDocuments":[{"name":"Gleason score","type":"Preferred Question Text","description":"Gleason score","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 2433 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"CCTG_01","type":"Alternate Question Text","description":"Total Gleason score","url":null,"context":"CCTG"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"96543902-0F49-1E9F-E053-F662850A5042","latestVersionIndicator":"Yes","beginDate":"2019-11-01","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-01","modifiedBy":"KUMMEROA","dateModified":"2023-11-22","changeDescription":"Released. AK 2020-6-17; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":"2023.11.22 AQT/Alt SN added per ticket request CADSR0003107. ak 02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}